Valganciclovir for ME

Cristina Montane's report from the XMRV workshop with Dr. Montoya and several Spanish Doctors:

Dr. José Montoya of Stanford University was next. He started explaining that six years ago he met his first CFS patient, and since then he has visited more than 450.

He is sure that you can develop CFS after a viral infection, and he believes that 11 % of patients that suffer EBV, Q fever, Ross River virus, etc, can end up with a CFS.

About Dr. Judy Mikovit’s paper he remarked that since it was published everybody is turning to CFS with the intention to find out all they can because they have completely changed their opinion.

In a random, double-blind, placebo-controlled study they have found that there was a clinical improvement in patients who were taking valganciclovir for a period of more than six months, compared with placebo.

CFS patients met Fukuda’s international criteria and had high antibody data against HHV-6 and EBV.

Several immunological markers changed significantly in the treated patients that were not seen in patients taking placebo. This study will be submitted for publication this month, and provides evidence that CFS is a real illness that can be caused by an infectious agent that can be treated with prolonged antiviral intervention.

They are also working on the hypothesis that besides the antiviral mechanism there could also be an immonumodulater component in the good results.